I henhold til Værdipapirhandelslovens §28a skal Novozymes offentliggøre følgende transaktioner under Fondskode DK0010272129, Novozymes B-aktier under betegnelsen NZYM B. Se hele meddelelsen
Recommended Reading
-
COPENHAGEN, Denmark – August 19, 2026. Novonesis delivered strong first half of 2026 at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% (previously 5-7%), and the...
Read More -
Strong first half year at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% and the adjusted EBITDA margin expected at the higher end of the 37-38% range. Inaugural share...
Read More